Joseph Walter Vazzano
Net Worth

Last updated:

What is Joseph Walter Vazzano net worth?

The estimated net worth of Mr. Joseph Walter Vazzano is at least $1,412,221 as of 15 Sep 2021. He owns shares worth $38,499 as insider, has earned $84,382 from insider trading and has received compensation worth at least $1,289,340 in Avenue Therapeutics, Inc..

What is the salary of Joseph Walter Vazzano?

Mr. Joseph Walter Vazzano salary is $214,890 per year as Chief Financial Officer, Principal Financial Officer & Company Sec. in Avenue Therapeutics, Inc..

How old is Joseph Walter Vazzano?

Mr. Joseph Walter Vazzano is 41 years old, born in 1984.

What stocks does Joseph Walter Vazzano currently own?

As insider, Mr. Joseph Walter Vazzano owns shares in one company:

Company Title Shares Price per share Total value
Avenue Therapeutics, Inc. (ATXI) Chief Financial Officer, Principal Financial Officer & Company Sec. 65,252 $0.59 $38,499

What does Avenue Therapeutics, Inc. do?

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.

ATXI logo
ATXI
Avenue Therapeutics, Inc.
$0.59

Joseph Walter Vazzano insider trading

Avenue Therapeutics, Inc.

Mr. Joseph Walter Vazzano has made 4 insider trades between 2019-2021, according to the Form 4 filled with the SEC. Most recently he sold 7,160 units of ATXI stock worth $11,599 on 15 Sep 2021.

The largest trade he's ever made was exercising 7,160 units of ATXI stock on 15 Sep 2021. As of 15 Sep 2021 he still owns at least 65,252 units of ATXI stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 7,160 $1.62 $11,599
Sale
Common Stock 3,840 $12.13 $46,579
Purchase
Common Stock 1,889 $7.94 $14,999
Purchase
Common Stock 1,500 $7.98 $11,970
Purchase
Common Stock 1,500 $7.98 $11,970
Purchase
Common Stock 1,200 $9.09 $10,908
Sale
Common Stock 2,375 $5.56 $13,205
Sale
Common Stock 2,313 $5.62 $12,999

Avenue Therapeutics key executives

Avenue Therapeutics, Inc. executives and other stock owners filed with the SEC:

  • Dr. Xiaoqin Lu M.D. (50) Pres, Chief Executive Officer & Director
  • Mr. Joseph Walter Vazzano (41) Chief Financial Officer, Principal Financial Officer & Company Sec.